Temporo-spatial distribution of endothelial-monocyte activating polypeptide II, an anti-angiogenic protein, in the mouse embryo

Developmental Dynamics

Volumn 218, Issue 3, 2000, Pages 490-498

  Zhang, Fangrong ^a   Schwarz, Margaret A ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Anti angiogenic protein; Endothelial monocyte activating polypeptide II; Heparin binding cytokines; Neovascularization

Indexed keywords

ANGIOGENIC FACTOR; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II; MESSENGER RNA; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL INTERACTION; EMBRYO; EPITHELIUM CELL; FETUS DEVELOPMENT; MESENCHYME; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOTTING, WESTERN; CELL COMMUNICATION; CYTOKINES; DENSITOMETRY; EMBRYO; EMBRYONIC AND FETAL DEVELOPMENT; EPITHELIUM; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MESODERM; MICE; NEOPLASM PROTEINS; RNA-BINDING PROTEINS; TIME FACTORS;

VERTEBRATA;

EID: 0033925118     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0177(200007)218:3<490::AID-DVDY1005>3.0.CO;2-C     Document Type: Article

References (21)

1. Baldwin HS. 1996. Early embryonic vascular development. Cardiovasc Res E34-45.
2. Coffin J D, Harrison J, Schwartz S, Heimark R. 1991. Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. Dev Biol 148:51-62.
3. Drake CJ, Little CD. 1995. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc Natl Acad Sci USA 92: 7657-61.
4. Flamme I, von Reutern M, Drexler H C, Syed-Ali S, Risau W. 1995. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Dev Biol 171: 399-414.
5. Gebb S, Shannon J. 1998. Tissue interactions mediate early events in pulmonary vasculogenesis. Am J Respir Crit Care Med 157:A208.
6. Kao J, Ryan J, Brett G, Chen J, Shen H, Fan Y G, Godman G, Familletti P C, Wang F, Pan YC, et al. 1992. Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. J Biol Chem 267:20239-47.
7. Kao J, Fan Y G, Haehnel I, Clauss M, Stern D. 1993. Endothelial-monocyte activating polypeptides (EMAPs): tumor derived mediators which activate the host inflammatory response. Behring Inst Mitt 92:92-106.
8. Kao J, Houck K, Fan Y, Haehnel I, Libutti S K, Kayton M L, Grikscheit T, Chabot J, Nowygrod R, Greenberg S, et al. 1994. Characterization of a novel tumor-derived cytokine. Endothelial- monocyte activating polypeptide II. J Biol Chem 269:25106-19.
9. Knies U E, Behrensdorf H A, Mitchell C A, Deutsch U, Risau W, Drexler H C, Clauss M. 1998. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. Proc Natl Acad Sci USA 95:12322-12327.
10. Merenmies J, Rauvala H. 1990. Molecular cloning of the 18-kDa growth-associated protein of developing brain. J Biol Chem 265: 16721-16724.
11. Mitsiadis T A, Salmivirta M, Muramatsu T, Muramatsu H, Rauvala H, Lehtonen E, Jalkanen M, Thesleff I. 1995. Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development 121:37-51.
12. Muramatsu T. 1993. Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation. Int J Dev Biol 37:183-188.
13. Muramatsu H, Muramatsu T. 1991. Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors. Biochem Biophys Res Commun 177:652-658.
14. Muramatsu H, Shirahama H, Yonezawa S, Maruta H, Muramatsu T. 1993. Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Dev Biol 159:392-402.
15. Poole T J, Coffin J D. 1989. Vasculogenesis and angiogenesis: two distinct morphogenetic mechanisms establish embryonic vascular pattern. J Exp Zool 251:224-231.
16. Rauvala H. 1989. An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors. Embo J 8:2933-2941..
17. Schwarz M A, Kandel J, Brett G, Li J, Hayward J, Schwarz R E, Chappey O, Wautier J, Chabot J, Lo Gerfo P, Stern D. 1999a. Endothelial-monocyte activating polypeptide ii, a novel antitumor cytokine that suppresses primary and metastatic tumor growth, and induces apoptosis in growing endothelial cells. J Exp Med 190:341-353..
18. Schwarz M, Lee M, Zhang F, Zhao J, Jin Y, Smith S, Bhuva J, Stern D, Warburton D, and Starnes V. 1999b. EMAP II: a modulator of neovascularization in the developing lung. Am J Physiol 276:L365-375.
19. Spectar D L, Goldman R D, Leinwand L A. 1998. Whole-mount in situ detection of rnas in vertebrate embryos and isolated organs. Cell: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, pp 117.1-117.15.
20. Wakasugi K, Schimmel P. Two distinct cytokines released from a human aminoacyl-tRNA synthetase [see comments]. Science 284: 147-151.
21. Yamaguchi T P, Dumont D J, Conlon R A, Breitman M L, Rossant J. 1993. flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118:489-498.